Ubiquitin-specific protease 25 (USP25)-PKM2-aerobic glycolysis axis positively modulates M1-like polarization and accelerates ischemic AKI in mice, indicating potential therapeutic targets for AKI treatment (Figure 3). This evidence concerns the gene USP25 and acute kidney injury.